Replies to post #95423 on Cytodyn Inc (CYDY)

[hopester]

Point taken. To support it, Pfizer just inked a deal with Atherys ( a small stem cell company ) getting no press at all ) holding great promise, for the right to their Multi-stem cell for the use in one of Athery's trials for one disease ATHX is testing. Now in phase 2 or 3
Pfizer also said earlier, that they'd be doing no big acquistions but will aggressively be looking for small companies that expand their pipeline.
I thingk BP is looking around at these promising little companies.

[awayfromhome]

I have contacts that work at those BP companies. They won't even talk to me about Leronlimab or CytoDyn. I think they're very afraid.>>

___________________________

No wonder. This is also why Dr. Fauci, "our national treasure," would rather bite his tongue off before saying "Leron..." If Leronlimab is allowed to commercialize Gilead will be history and the entire mega corporate racket called US pharmaceutics and biotech industry shattered in its foundations. And hundreds of thousands of the upper 5% invested in it. This is the one and only true risk CYDY faces. And it yet could be proved insurmountable.

[hitekmastr]

Just before the HIV approval date, a BP will make a buyout offer. However, they make make an offer really fast if the COVID data is strong because otherwise they won't be able to afford the acquisition since the stock price and cost to buy will be astronomical if CYDY has an HIV approval coming PLUS 2 successful COVID trials - not to mention breast cancer, NASH, uplisting and all the other cancer trials.

From another perspective, it would be difficult for CYDY to cover the cost of all the trials progressing to phase 3 and beyond even if revenues from HIV and COVID are super high. So partnering with BP makes sense and also allows Dr. N to cash out and "semi retire."